GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Beginning Cash Position

Crescita Therapeutics (TSX:CTX) Beginning Cash Position : C$9.01 Mil (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Beginning Cash Position?

Crescita Therapeutics's Beginning Cash Position for the quarter that ended in Sep. 2024 was C$9.01 Mil.

Crescita Therapeutics's quarterly Beginning Cash Position increased from Mar. 2024 (C$9.39 Mil) to Jun. 2024 (C$9.53 Mil) but then declined from Jun. 2024 (C$9.53 Mil) to Sep. 2024 (C$9.01 Mil).

Crescita Therapeutics's annual Beginning Cash Position declined from Dec. 2021 (C$14.28 Mil) to Dec. 2022 (C$11.33 Mil) and declined from Dec. 2022 (C$11.33 Mil) to Dec. 2023 (C$8.24 Mil).

Crescita Therapeutics Beginning Cash Position Historical Data

The historical data trend for Crescita Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Beginning Cash Position Chart

Crescita Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.59 9.27 14.28 11.33 8.24

Crescita Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.20 9.92 9.39 9.53 9.01

Crescita Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Crescita Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Beginning Cash Position
Comparable Companies
XCNQ:XTRX TSX:VPH XCNQ:CANN TSX:XLY TSXV:MPH XCNQ:RVV XCNQ:BAMM TSX:WLLW XCNQ:SLNG NEOE:TILT ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
CRRTF:USA
Address
2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3
Website
https://www.crescitatherapeutics.com
Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue from Commercial Skincare Product Sales in Canada.
Executives
Daniel Chicoine Director, Senior Officer
Jose Darocha Director, Senior Officer
Serge Verreault Senior Officer
Anthony Edward Dobranowski Director
Knight Therapeutics Inc. 10% Security Holder

Crescita Therapeutics Headlines

No Headlines